Skip to main content

Syncom Healthcare Limited (SYNCOM.NS)

National Stock Exchange of India Healthcare Drug Manufacturers - Specialty & GenericView data quality →
38.4Poor

ValueMarkers Composite Index

Top 3%#43,191 of 44,714

DCF data not available

Piotroski
4/9
Neutral
Beneish
-4.22
Low Risk
Altman
-2.13
Distress
DCF Value
-
N/A
ROIC
-73.0%
Low
P/E
-
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Syncom Healthcare Limited (SYNCOM.NS) — VMCI valuation read

SYNCOM.NS prints VMCI 38/100 inside the Healthcare sector, where the median sits at 50. The 12-point below-median delta is the cleanest single-number summary of Syncom Healthcare Limited's composite stance, and in the mid-cap bucket it places the share behind the typical peer on the five-pillar mix.

On SYNCOM.NS, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.

**Investor frame.** SYNCOM.NS trades at 16.0x earnings, 11% below the Healthcare median of 18.0x; that is the value line. ROIC of 18.0% sits 8.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of 3.2x is the binding constraint on the bear case; that is the risk line for Syncom Healthcare Limited on the trailing financials.

SYNCOM.NS rose 2.1% over the trailing 7 days, with a +4.3% read on a 30-day basis.

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in SYNCOM.NS’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.